Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melan-A VLP Vaccine in Advanced Melanoma
NCT00306553Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of CYT004-MelQbG10 in Malignant Melanoma (MM), sponsored by Cytos Biotechnology AG. Status: completed.
02
Drugs
CYT004-MelQbG10
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00306553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306553.